Skip to main content

Creative Biolabs’ Innovative Microbial Identification Solutions Propel Live Biotherapeutic Research

By: Get News
Creative Biolabs, a leading Contract Research Organization (CRO), is empowering the research progress of live biotherapeutics with its state-of-the-art microbial identification services.

New York, USA - June 28, 2023 - Microbial identification services play a pivotal role in the rapidly evolving landscape of live biotherapeutics. Creative Biolabs is at the forefront, providing a range of high-quality and reliable services that facilitate in-depth analysis and characterization of microbial populations.

Creative Biolabs specializes in nucleic acid analytics, utilizing state-of-the-art molecular methods to analyze the genetic makeup of live biotherapeutic products. Through the application of advanced high-throughput sequencing technologies, scientists can swiftly detect and measure individual microbial species within intricate populations. This approach grants significant insights into the functional roles of these species, creating opportunities for precise therapeutic interventions.

Moreover, the utilization of next-generation sequencing empowers researchers to delve into the intricacies of microbial communities linked to live biotherapeutic products, uncovering their diversity and structure. This potent approach allows for the unraveling of complex relationships between microorganisms, facilitating a deeper comprehension of the ecological dynamics within the microbial ecosystem. By leveraging their expertise in next-generation sequencing techniques, Creative Biolabs excels in community analysis, offering invaluable insights for the optimization of therapeutic interventions.

Creative Biolabs offers a cost-effective whole metagenomic profiling service that covers the entire process, including high-quality genomic DNA extraction, library preparation, and sequencing using the Illumina HiSeq PE150 platform. Clients can confidently explore their metagenomic sequencing needs with the seamless and affordable solution. Additionally, this company provides a metatranscriptomics profiling service that enables researchers to study RNA transcripts within a microbial community, identify crucial pathways involved in disease progression or mitigation, and optimize the therapeutic potential of live biotherapeutic products.

A scientist at Creative Biolabs emphasizes the company's commitment to supporting researchers in advancing live biotherapeutic products: "Our microbial identification services harness the power of advanced molecular techniques, providing researchers with the critical knowledge needed to develop innovative therapeutic solutions. We are dedicated to pushing the boundaries of live biotherapeutic research."

As the demand for live biotherapeutic products continues to grow, Creative Biolabs remains at the forefront of innovation. With their high-quality microbial identification services, researchers worldwide can unlock the full potential of live biotherapeutics and revolutionize the treatment of human diseases.

Learn more, please refer to https://live-biotherapeutic.creative-biolabs.com.

About Creative Biolabs

Creative Biolabs is a highly regarded CRO that has established itself as a leader in the advancement of live biotherapeutic products. With a diverse range of services, including nucleic acid analytics, community analysis, whole metagenomic profiling, and metatranscriptomics profiling, this company offers extensive support to researchers pursuing innovative therapeutic solutions. Its expertise and comprehensive assistance empower researchers to make significant strides in the development of groundbreaking therapies.

Media Contact
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email
Phone: 1-631-830-6441
Country: United States
Website: https://live-biotherapeutic.creative-biolabs.com



Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.